COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 367: Articles 3661-3670  | Next

In Vivo Antiviral Efficacy of LCTG-002, a Pooled, Purified Human Milk Secretory IgA product, Against SARS-CoV-2 in a Murine Model of COVID-19
Mane, V., Mehta, R., Alvarez, N., Sharma, V., Park, S., Fox, A., DeCarlo, C., Yang, X., Perlin, D. S., Powell, R. L.
10.1101/2023.08.25.554813 — Posted: 2023-08-28
Prevalence and pattern of Post Covid-19 symptoms in recovered patients of Delhi: A Population-Based study
Bhatnagar, N., Singh, M. M., Sharma, H., Mishra, S., Singh, G., Rao, S., Borle, A., Anand, T., Kumar, N., Goswami, B., Singh, S., Kapoor, M., Singla, S., Khuraijam, B., Khurana, N., Sharma, U., Garg, S.
10.1101/2023.08.25.23294654 — Posted: 2023-08-28
Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection
Goguet, E., Olsen, C., Meyer, W. A., Ansari, S., Powers, J. H., Conner, T. L., Coggins, S. A., Wang, W., Wang, R., Illinik, L., Sanchez Edwards, M., Jackson-Thompson, B. M., Hollis-Perry, M., Wang, G., Alcorta, Y., Wong, M. A., Saunders, D., Mohammed, R., Balogun, B., Kobi, P., Kosh, L., Bishop-Lilly, K., Cer, R. Z., Arnold, C. E., Voegtly, L. J., Fitzpatrick, M., Luquette, A. E., Malagon, F., Ortega, O., Parmelee, E., Davies, J., Lindrose, A. R., Haines-Hull, H., Moser, M. S., Samuels, E. C., Tso, M. S., Graydon, E., Malloy, A. M. W., Tribble, D. R., Burgess, T. H., Campbell, W., Robinson, S.
10.1101/2023.08.25.23294626 — Posted: 2023-08-28
Kinetics and durability of humoral responses to SARS-CoV-2 infection and vaccination
Srivastava, K., Carreno Quiroz, J. M., Gleason, C., Monahan, B., Singh, G., Abbad, A., Tcheou, J., Raskin, A., Kleiner, G., van Bakel, H., Sordillo, E. M., PARIS Study Group, , Krammer, F. M., Simon, V.
10.1101/2023.08.26.23294679 — Posted: 2023-08-28
Single-cell-resolved interspecies comparison identifies a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19
Peidli, S., Nouailles, G., Wyler, E., Adler, J. M., Kunder, S., Voss, A., Kazmierski, J., Pott, F., Pennitz, P., Postmus, D., Teixeira Alves, L. G., Goffinet, C., Gruber, A. D., Bluethgen, N., Witzenrath, M., Trimpert, J., Landthaler, M., Praktiknjo, S. D.
10.1101/2023.08.25.551434 — Posted: 2023-08-27
Real-time identification of epistatic interactions in SARS-CoV-2 from large genome collections
Innocenti, G., Galardini, M.
10.1101/2023.08.22.554253 — Posted: 2023-08-26
Participatory Approaches in Community Health in light of the COVID-19 Pandemic: A Scoping Review Protocol
Frahsa, A., Liwanag, H. J., Kobler, C., Ipekci, A. M., Minder, B., Schow, D.
10.1101/2023.08.24.23294551 — Posted: 2023-08-25
Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals
Moguem Soubgui, A. F., Ndeme Mboussi, W. S., Kojom Foko, L. P., Embolo Enyegue, E. L., Koanga Mogtomo, M. L.
10.1101/2023.08.24.23294559 — Posted: 2023-08-25
Rates of SARS-CoV-2 transmission between and into California state prisons
Dubey, P., Hoover, C., Lu, P., Blumberg, S., Porco, T. C., Parsons, T. L., Worden, L.
10.1101/2023.08.24.23294583 — Posted: 2023-08-25
Determinants of health-related quality of life in healthy children and adolescents during the COVID-19 pandemic: results from the longitudinal cohort study Ciao Corona
Haile, S. R., Peralta, G. P., Raineri, A., Rueegg, S., Ulyte, A., Puhan, M. A., Radtke, T., Kriemler, S.
10.1101/2023.08.25.23294563 — Posted: 2023-08-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).